Alphatec Holdings (ATEC) Q2 FY26 earnings call

Alphatec Holdings delivered robust Q2 FY26 results, showcasing strong revenue growth and significant profitability expansion, driven by consistent surgeon adoption and increasing procedural volumes. The company's strategic focus on clinical distinction and integrated procedural solutions continues to yield positive financial outcomes, with expanding EBITDA margins and positive free cash flow. Management remains confident in its full-year outlook, emphasizing continued execution and the long-term potential of its ecosystem, despite some pressure on revenue per case from mix and biologics.